SEQUENOM
Sequenom designs, develops, manufactures and markets innovative technology, instrumentation and tests that target and serve discovery and clinical research, and clinical molecular diagnostics markets. Applications include translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders.
SEQUENOM
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
1994-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.sequenom.com
Total Employee:
501+
Status:
Active
Contact:
8582029031
Total Funding:
185.32 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS GStatic Google Static Content Cloudflare Hosting
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Illumina Accelerator
Illumina Accelerator is a company creation engine focused on building breakthrough genomics startups!
Current Advisors List
Board_member
Current Employees Featured
Toni Schuh President @ Sequenom
President
Hubert Koster Founder @ Sequenom
Founder
Dirk van den Boom EVP, Chief Scientific & Strategy Officer @ Sequenom
EVP, Chief Scientific & Strategy Officer
Carolyn Beaver Senior Vice President & CFO @ Sequenom
Senior Vice President & CFO
William Welch President & CEO @ Sequenom
President & CEO
Jeff Linton SVP, General Counsel & Secretary @ Sequenom
SVP, General Counsel & Secretary
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-01-27 | SensiGen | SensiGen acquired by Sequenom | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Sequenom
Official Site Inspections
http://www.sequenom.com
- Host name: ec2-54-159-234-47.compute-1.amazonaws.com
- IP address: 54.159.234.47
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Sequenom"
Sequenom - Crunchbase Company Profile & Funding
Organization. Sequenom . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Sequenom offers genetic analysis products and …See details»
SEQUENOM: Quantitative Gene Expression Analysis
SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for molecular medicine and biomedical research. The cornerstone of SEQUENOM's approach is the …See details»
Sequenom Company Profile 2024: Valuation, Investors …
When was Sequenom founded? Sequenom was founded in 1994. Where is Sequenom headquartered? Sequenom is headquartered in San Diego, CA. What is the size of Sequenom? Sequenom has 434 total employees. What industry …See details»
Sequenom, Inc. Company Profile | San Diego, CA | Competitors ...
Company Description: Sequenom develops and manufactures tests for the molecular diagnostics market. Its lab-developed tests are primarily focused on prenatal and ophthalmological …See details»
Company Profile: Sequenom, Inc. - Taylor & Francis Online
Mar 30, 2012 The author is an employee of Sequenom, Inc. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or …See details»
Sequenom - LinkedIn
Sequenom | 8,586 followers on LinkedIn. In 2016, Sequenom was acquired by LabCorp. We are excited to continue to support women’s health under the Labcorp name. | We are excited to …See details»
Company profile: Sequenom, Inc - PubMed
1 Sequenom, Inc., 3595 John Hopkins Ct, San Diego, CA 92121, USA. ccantor@sequenom.com; PMID: 22462745 DOI: 10.2217/pgs.12.8 Abstract There is broad acceptance in both the …See details»
News – Agena Bioscience Acquires Sequenom, Inc.’s…
May 30, 2014 John Lillig to Lead Agena Bioscience as Chairman and Interim CEO. San Diego, Calif. – May 30, 2014 – Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners …See details»
Sequenom Company Profile - Office Locations, Competitors ... - Craft
Sequenom is a company specializing in genetic testing. It focuses on prenatal care. Sequenom's molecular genetic tests provide early patient management information for obstetricians, …See details»
Integrated Genetics, Sequenom | San Diego | Labcorp
3595 John Hopkins Court, San Diego, CA 92121-1121 Regional/National Toll-free Telephone: 877-821-7266See details»
Sequenom Center for Molecular Medicine LLC - OpenNPI
Sequenom Center for Molecular Medicine LLC is a Clinical Medical Laboratory (organization) practicing in San Diego, California. The National Provider Identifier (NPI) is #1730481078, …See details»
Cooley Secures Win for Sequenom Board in Securities Class Action
San Diego – September 12, 2023 – Cooley represented the former board of directors of Sequenom, a molecular diagnostics company, in a nearly seven-year-long securities class …See details»
LabCorp's Takeover of Sequenom Wins Antitrust Clearance
Aug 25, 2016 Berkshire's cash soars to $325 billion as Buffett sells Apple, BofA; operating profit falls (Reuters) -Warren Buffett and Berkshire Hathaway extended their retreat from stocks in …See details»
Sequenom : Sequenom to Provide Quantitative Gene Expression …
May 31, 2007 Sequenom, Inc. today announced that it will provide quantitative gene expression services to the Immune Tolerance Network , a collaborative research organization that solicits, ...See details»
Sequenom , Inc.: Pharmacogenomics: Vol 9 , No 9 - Get Access
Amy Cullinan (Technical and Marketing Communications) and Charles Cantor (Chief Scientific Officer) are both employees of Sequenom, Inc. The authors have no other relevant affiliations …See details»
Sequenom (Now LabCorp Women's Health) | XiFin, Inc.
Sequenom, Inc. (Now LabCorp Women's Health) is a life sciences company committed to improving healthcare through revolutionary genomic and genetic analysis solutions. …See details»
Three years on, what have we learned about non-invasive prenatal ...
Oct 17, 2014 Sequenom’s technology is not patentable. Soon after each test entered the market, lawsuits were filed against each other for claims of patent infringements. ... Every professional …See details»
Mutation profiling in tumor samples using the Sequenom OncoCarta
Sequenom's MassARRAY ® system enables sensitive and rapid somatic mutation profiling in solid tumors or cell lines. Our validation studies revealed mutations in most of the oncogenes …See details»
Sequenom: The Last Chapter Is A Head Scratcher - Seeking Alpha
Sequenom +4%. Gross Margin: Natera declined from 48% to 40%. Sequenom improved from 39% to 53%. Operating loss: The Natera loss increased by 134% to $22.5 million. The …See details»